Respiratory Medicine and Dyspnea in Advanced Lung Disease
Clinical research includes the assessment of dyspnea perception in patients with advanced respiratory disease, with interest in symptom control and patient-reported breathing discomfort. The sponsored work also reflects attention to inhaled therapies used in palliative respiratory care and symptom relief.
- Advanced lung disease
- Dyspnea assessment
- Inhaled therapy
These studies are centered on clinically significant breathing symptoms that affect daily functioning and quality of life in severe pulmonary conditions.
Hematology and Immune Thrombocytopenia
The sponsor is active in research on immune thrombocytopenia, with a therapeutic focus on improving platelet-related outcomes through immunomodulatory treatment. This area reflects interest in disorders of immune-mediated blood cell destruction and their clinical management.
- Immune thrombocytopenia
- Immunomodulatory therapy
- Platelet disorders
The research domain addresses treatment approaches for a hematologic condition where immune regulation is central to disease control.
Neurology and Ischemic Stroke
Clinical investigation also covers ischemic stroke, with emphasis on reducing brain injury and protecting vascular structures involved in cerebral ischemia. The therapeutic interest extends to mechanisms linked to endothelial function and vascular integrity in acute neurological disease.
- Ischemic stroke
- Brain ischemia
- Endothelial protection
This area connects neurological outcomes with vascular biology, particularly in conditions where blood flow disruption leads to tissue damage.
Vascular Biology and Endothelial Glycocalyx
The sponsor supports research on albumin as a means of protecting the endothelial glycocalyx and preserving microvascular function. This line of interest sits at the intersection of vascular medicine, endothelial health, and tissue protection in serious systemic illness.
- Endothelial glycocalyx
- Microvascular function
- Albumin
The focus highlights biological pathways relevant to vascular stability and organ protection across critical disease settings.
